Thrombospondin-2 appears to be a good therapeutic candidate for prevention of adverse remodeling, which has previously been implicated through gene expression microarrays of murine HF models as a regulator of myocardial fibrosis, repair, and MMPs19,42–44. The gene discussed is THBS2; the disease is hydrops fetalis.